산후 출혈 치료 기기 시장 : 제품, 사용성, 유통 채널, 용도별 - 세계 예측(2025-2030년)

The Postpartum Hemorrhage Treatment Devices Market was valued at USD 812.89 million in 2023, expected to reach USD 860.94 million in 2024, and is projected to grow at a CAGR of 6.25%, to USD 1,242.95 million by 2030.

Postpartum hemorrhage (PPH) treatment devices are essential medical tools designed to manage and control excessive bleeding following childbirth, a leading cause of maternal mortality globally. The necessity for these devices stems from the need to ensure maternal safety and reduce mortality rates by providing rapid and effective interventions. These devices, which include balloon tamponade, non-pneumatic anti-shock garments, and advanced blood clotting agents, are employed primarily in healthcare facilities such as hospitals and maternity clinics. The end-use of these devices predominantly involves obstetricians, gynecologists, and other maternity care professionals focused on optimizing maternal healthcare standards.

A key growth factor in this market is the increasing awareness and emphasis on maternal health in both developed and developing regions, alongside technological advancements in medical devices. Additionally, a rise in healthcare expenditures and support from government initiatives to improve maternal care contribute to market expansion. Potential opportunities include the development of cost-effective and portable devices, particularly crucial for resource-limited settings. Companies can also leverage digital technology for training and education on device usage, enhancing adoption rates among healthcare workers.

Challenges limiting market growth include the high cost of advanced devices, limited access in low-income regions, and a deficit of skilled healthcare professionals trained in the usage of such equipment. Regulatory hurdles also pose a significant barrier to entry for new players and innovations. To overcome these limitations, innovation could focus on creating economically viable, user-friendly devices that integrate smart technology for ease of use and monitoring. Further research could explore the development of multifunctional devices that address multiple aspects of obstetric care. The market remains dynamic, with numerous players investing in R&D to enhance device efficiency and safety. Stakeholders should focus on strategic collaborations to foster global distribution networks and training programs, ensuring the widespread implementation and acceptance of PPH treatment devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
  • High prevalence of postpartum hemorrhage
  • Ongoing healthcare reforms and initiatives aimed at improving maternal health services
• Market Restraints
  • High cost of postpartum hemorrhage treatment devices
• Market Opportunities
  • Technological advancements and launch of new PPH treatment devices
  • Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
• Market Challenges
  • Scarcity of trained healthcare providers

Porter's Five Forces: A Strategic Tool for Navigating the Postpartum Hemorrhage Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postpartum Hemorrhage Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postpartum Hemorrhage Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postpartum Hemorrhage Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postpartum Hemorrhage Treatment Devices Market

A detailed market share analysis in the Postpartum Hemorrhage Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postpartum Hemorrhage Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postpartum Hemorrhage Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postpartum Hemorrhage Treatment Devices Market

A strategic analysis of the Postpartum Hemorrhage Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Hemorrhage Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3RD Stone Design, Inc., Bactiguard Holding AB, Becton, Dickinson and Company, Cardinal Health, Inc., Cook Medical, Inc., GE HealthCare Technologies, Inc., Laborie Medical Technologies, Inc., Merck & Co., Inc., Organon & Co., Procurenet Limited, Ribbel International Limited, Sinapi Biomedical, Teleflex, Inc., and Utah Medical Products Inc..

Market Segmentation & Coverage

This research report categorizes the Postpartum Hemorrhage Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, and Uterine Tamponade Devices. The Uterine Tamponade Devices is further studied across Balloon Tamponade and Foley Catheter.
• Based on Usability, market is studied across Disposable Devices and Reusable Devices.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Application, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
    • 5.1.1.2. High prevalence of postpartum hemorrhage
    • 5.1.1.3. Ongoing healthcare reforms and initiatives aimed at improving maternal health services
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of postpartum hemorrhage treatment devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and launch of new PPH treatment devices
    • 5.1.3.2. Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of trained healthcare providers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significant benefits of non-pneumatic anti-shock garments as an immediate and temporary measure
  • 5.2.2. Distribution Channel: Higher preferences for offline distribution channels for quick product accessibility
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Postpartum Hemorrhage Treatment Devices Market, by Product

• 6.1. Introduction
• 6.2. Non-Pneumatic Anti-Shock Garment
• 6.3. Prefilled Injection System
• 6.4. Uterine Tamponade Devices
  • 6.4.1. Balloon Tamponade
  • 6.4.2. Foley Catheter

7. Postpartum Hemorrhage Treatment Devices Market, by Usability

• 7.1. Introduction
• 7.2. Disposable Devices
• 7.3. Reusable Devices

8. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Postpartum Hemorrhage Treatment Devices Market, by Application

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Hospitals

10. Americas Postpartum Hemorrhage Treatment Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Postpartum Hemorrhage Treatment Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Postpartum Hemorrhage Treatment Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Laborie Medical Technologies Corp. Acquires Urotronic, Inc. to Enhance Interventional Urology Portfolio
  • 13.3.2. Medtrade and Kebomed Europe AG Join Forces to Enhance Postpartum Hemorrhage Care Across Europe
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3RD Stone Design, Inc.
• 2. Bactiguard Holding AB
• 3. Becton, Dickinson and Company
• 4. Cardinal Health, Inc.
• 5. Cook Medical, Inc.
• 6. GE HealthCare Technologies, Inc.
• 7. Laborie Medical Technologies, Inc.
• 8. Merck & Co., Inc.
• 9. Organon & Co.
• 10. Procurenet Limited
• 11. Ribbel International Limited
• 12. Sinapi Biomedical
• 13. Teleflex, Inc.
• 14. Utah Medical Products Inc.